Get the Stockscreener App
190.22
0.29%
-0.55
After Hours:
190.22
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health Inc stock is traded at $190.22, with a volume of 2.50M.
It is down -0.29% in the last 24 hours and up +23.15% over the past month.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
See More
Previous Close:
$190.77
Open:
$191.07
24h Volume:
2.50M
Relative Volume:
1.02
Market Cap:
$45.19B
Revenue:
$234.31B
Net Income/Loss:
$1.61B
P/E Ratio:
28.72
EPS:
6.6243
Net Cash Flow:
$1.85B
1W Performance:
+16.13%
1M Performance:
+23.15%
6M Performance:
+27.21%
1Y Performance:
+63.80%
1-Day Range:
$188.15
$192.47
1-Week Range:
$161.64
$197.67
52-Week Range:
$110.63
$197.67
Cardinal Health Inc Stock (CAH) Company Profile
Name
Cardinal Health Inc
Sector
Industry
Phone
(614) 757-3033
Address
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
190.22 | 45.33B | 234.31B | 1.61B | 1.85B | 6.6243 |
|
MCK
Mckesson Corporation
|
820.29 | 100.92B | 377.60B | 3.35B | 5.67B | 25.06 |
|
COR
Cencora Inc
|
340.93 | 65.49B | 316.65B | 1.91B | 1.14B | 9.7209 |
|
HSIC
Henry Schein Inc
|
64.64 | 7.66B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.60 | 889.76M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-05-25 | Upgrade | Jefferies | Hold → Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-06-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-13-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Upgrade | Argus | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Underweight |
| Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-23 | Initiated | Citigroup | Neutral |
| Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
| May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
| May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-27-19 | Downgrade | Argus | Buy → Hold |
| Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-18-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Apr-02-18 | Upgrade | Argus | Hold → Buy |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Underperform |
| Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health Inc Stock (CAH) Latest News
Key facts: Cardinal Health acquires Solaris Health; TD Cowen raises price target - TradingView
Jefferies Raises Cardinal Health's Price Target to $220 From $190 - MarketScreener
Cardinal Health (CAH): TD Cowen Raises Price Target to $225 | CA - GuruFocus
Real time social sentiment graph for Cardinal Health Inc.Weekly Investment Recap & Verified Stock Trade Ideas - newser.com
Cardinal Health completes acquisition of Solaris Health - Investing.com
TD Cowen Adjusts Price Target on Cardinal Health to $225 From $183 - MarketScreener
Cardinal Health (NYSE: CAH) completes Solaris Health deal, adds 750 providers in 14 states - Stock Titan
Wakefield Asset Management LLLP Sells 1,445 Shares of Cardinal Health, Inc. $CAH - MarketBeat
iA Global Asset Management Inc. Acquires 10,083 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Kesler Norman & Wride LLC Takes Position in Cardinal Health, Inc. $CAH - MarketBeat
Plato Investment Management Ltd Raises Stake in Cardinal Health, Inc. $CAH - MarketBeat
Will Cardinal Health Inc. (CLH) stock outperform Dow JonesCEO Change & Verified Short-Term Plans - newser.com
Q2 EPS Estimates for Cardinal Health Increased by Analyst - MarketBeat
Is Cardinal Health Inc. stock vulnerable to regulatory risksOptions Play & Verified Momentum Stock Watchlist - newser.com
How cyclical is Cardinal Health Inc. stock compared to rivalsLong Setup & Weekly Return Optimization Plans - newser.com
Tools to monitor Cardinal Health Inc. recovery probabilityTrade Signal Summary & Technical Pattern Based Signals - newser.com
When is the best time to exit Cardinal Health Inc.Gap Up & Stepwise Entry and Exit Trade Signals - newser.com
Cardinal Health raises 2026 EPS guidance to $9.65–$9.85 amid strong double-digit segment growth and Solaris Health acquisition - MSN
Leerink Partners Forecasts Strong Price Appreciation for Cardinal Health (NYSE:CAH) Stock - MarketBeat
Longbow Finance SA Has $7.59 Million Stock Holdings in Cardinal Health, Inc. $CAH - MarketBeat
How Cardinal Health Inc. stock valuation compares with sectorPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
How Cardinal Health Inc. stock trades before earningsJuly 2025 Price Swings & High Win Rate Trade Tips - newser.com
Trend analysis for Cardinal Health Inc. this weekQuarterly Performance Summary & Risk Managed Trade Strategies - newser.com
Assetmark Inc. Buys 1,989 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Spire Wealth Management Boosts Position in Cardinal Health, Inc. $CAH - MarketBeat
Atria Investments Inc Boosts Stock Holdings in Cardinal Health, Inc. $CAH - MarketBeat
World Investment Advisors Acquires 2,168 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Oppenheimer Asset Management Inc. Makes New Investment in Cardinal Health, Inc. $CAH - MarketBeat
Ashton Thomas Private Wealth LLC Takes $278,000 Position in Cardinal Health, Inc. $CAH - MarketBeat
Is a relief rally coming for Cardinal Health Inc. holdersJuly 2025 Gainers & Weekly High Conviction Trade Ideas - newser.com
Will Cardinal Health Inc. (CLH) stock enhance shareholder valueMarket Activity Summary & Community Consensus Stock Picks - newser.com
Cardinal Health (NYSE:CAH) Price Target Raised to $190.00 at Citigroup - MarketBeat
Cardinal Health (CAH) “Is Now Value-Added,” Says Jim Cramer - MSN
Cardinal Health, Inc. Hits New 52-Week High of $195.15 - Markets Mojo
Understanding Cardinal Health Inc.’s price movementFed Meeting & Smart Money Movement Tracker - newser.com
Cardinal Health surges as it raises FY 2026 EPS guidance - MSN
Cardinal Health (NYSE:CAH) Stock Price Expected to Rise, Evercore ISI Analyst Says - MarketBeat
Cardinal Health, Inc. (NYSE:CAH) Q1 2026 Earnings Call Transcript - Insider Monkey
Amalgamated Bank Boosts Stake in Cardinal Health, Inc. $CAH - MarketBeat
Arkadios Wealth Advisors Acquires 11,708 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Howard Capital Management Inc. Makes New Investment in Cardinal Health, Inc. $CAH - MarketBeat
Y Intercept Hong Kong Ltd Cuts Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health (CAH) Earnings Growth Surpasses Average, Raises Questions About Premium Valuation - Sahm
Using R and stats models for Cardinal Health Inc. forecastingJuly 2025 Catalysts & Detailed Earnings Play Strategies - newser.com
Cardinal Health (CAH) Analyst Rating Update: Citigroup Raises Pr - GuruFocus
Cardinal Health (NYSE:CAH) Announces Quarterly Earnings Results, Beats Estimates By $0.33 EPS - MarketBeat
How Recent Developments Are Shaping the Cardinal Health Investment Story - Yahoo Finance
Cardinal Health (CAH) Hits New 52-Week High on Earnings, Optimistic Outlook - MSN
Cardinal Health (NYSE:CAH) Reaches New 52-Week High Following Better-Than-Expected Earnings - MarketBeat
CAH Q3 Deep Dive: Specialty Expansion, M&A Drive Strong Top-Line Growth - TradingView
Evercore ISI Raises Price Target for Cardinal Health (CAH) to $2 - GuruFocus
Cardinal Health Inc Stock (CAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.92%
1.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):